Atossa Therapeutics, Inc. (NasdaqCM:ATOS) is looking for acquisitions. President and Chief Executive Officer, Dr. Steven Quay, said "we are also actively evaluating potential acquisition/in-licensing opportunities of new programs to further drive stockholder value".